Tanger Inc. (SKT) is a publicly traded company in the Real Estate — REIT - Retail industry listed on NYSE. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Tanger Inc. (NYSE: SKT) stands as a prominent owner and operator of outlet and open-air retail shopping destinations, leveraging over 43 years of extensive expertise within the retail and outlet sectors. Its expansive portfolio comprises 38 outlet centers, an adjacent managed facility, and an open-air lifestyle complex, collectively encompassing more than 15 million square feet.
Is Tanger Inc. stock overvalued or undervalued in 2026?
Tanger Inc. (SKT) trades at 33.4× earnings (P/E). At its 10-year average P/FFO (10.0×) $26 (-29 %); at the decade median (9.4×) $25 (-33 %).
Kaplio overview: Tanger Inc.
Market cap $4B · 52 weeks $32 – $42 (12 % below the high) · P/E 33.4× · 2027 expected P/E 32.7× · Dividend 3.3 % · 5 years rising · Next earnings November 4, 2026 · expected EPS $0.27 · Closing price, Oct 30 · accounts published Aug 4.
- Valuation: P/FFO 14.1× (passes, near the threshold).
- Business: FFO/dividend 2.2× (solid).
- Balance sheet: Net debt/EBITDA 5.0× (solid).
- Earnings: 7 of 8 (no verdict).
What would it be worth at its usual multiples?
At its 10-year average P/FFO (10.0×) $26 (-29 %); at the decade median (9.4×) $25 (-33 %). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
What matters in REITs: 3 of 4 pass
- Debt / Assets 63.6 %, borderline.
- Dividend coverage (FFO/div) 2.2×, passes.
- Net debt / EBITDA 5.0×, passes.
- P/FFO 14.1×, passes, near the threshold.
- FFO / Share $2.61, info.
Against its peers (reference peers) — Tanger Inc.: P/B 6.2×; Div. yield 3.3 %; EV/EBITDA 16.2×; $4.2B. Phillips Edison & Co. (P/B 2.0×; Div. yield 3.4 %; EV/EBITDA 12.9×; $5.0B), The Macerich Company (P/B 2.4×; Div. yield 2.8 %; EV/EBITDA 28.8×; $7.2B), National Health Investors, Inc. (P/B 2.1×; Div. yield 5.5 %; EV/EBITDA 14.4×; $3.3B).
Expensive or cheap against its last ten fiscal years?
Precio / FFO (aprox.) at each close: today 14.1× · median 9.4× · minimum 5.6× · maximum 14.2× · cheap below 8.3× · expensive above 13.0×. It has been cheaper than today 90% of the time over its last ten fiscal years.
Dividend
solid · Yield 3.3 % ($1.17 per share in 2025) · Years raising it 5 · 5-year growth +10 % a year · Free cash flow coverage FFO payout 45 % · With $1,000 invested today you'd collect $32.90 a year ($2.74 a month).
Profitability
| Return on Equity | 18.64% |
| Return on Invested Capital | 6.72% |
| Return on Assets | 4.49% |
| Gross Margin | 69.54% |
| Operating Margin | 30.20% |
| Net Margin | 20.96% |
Financial Health
| Debt / Equity | 2.76 |
| Current Ratio | 1.83 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 1.28 |
Price Performance
| 1 month | +6.71% |
| 3 months | -9.59% |
| Year-to-date | +10.16% |
| 1 year | +12.90% |
| 3 years | +59.20% |
| 5 years | +107.33% |
| 10 years | +9.96% |
Dividend History
Paid in the last 12 months: $1.2300 per share in 4 payments.
| Date | Amount |
|---|---|
| 2026-10-30 | $0.3125 |
| 2026-07-31 | $0.3125 |
| 2026-04-30 | $0.3125 |
| 2026-01-30 | $0.2925 |
| 2025-10-31 | $0.2925 |
| 2025-07-31 | $0.2925 |
| 2025-04-30 | $0.2925 |
| 2025-01-31 | $0.2750 |
| 2024-10-31 | $0.2750 |
| 2024-07-31 | $0.2750 |
Amounts adjusted for stock splits.
Related companies: PECO · PSA · MAC · VNO · NHI · BNL · RYN · SHO
Explore sector: Real Estate · REIT - Retail
More sections of SKT: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks